CoChat

Cost-Effectiveness of a Program to Prevent Depression Relapse in Primary Care

The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.

Abstract

OBJECTIVE: Evaluate the incremental cost-effectiveness of a depression relapse prevention program in primary care. MATERIALS AND METHODS: Primary care patients initiating antidepressant treatment completed a standardized telephone assessment 6-8 weeks later. Those recovered from the current episode but at high risk for relapse (based on history of recurrent depression or dysthymia) were offered randomization to usual care or a relapse prevention intervention. The intervention included systematic patient education, two psychoeducational visits with a depression prevention specialist, shared decision-making regarding maintenance pharmacotherapy, and telephone and mail monitoring of medication adherence and depressive symptoms. Outcomes in both groups were assessed via blinded telephone assessments at 3, 6, 9, and 12 months and health plan claims and accounting data. RESULTS: Intervention patients experienced 13.9 additional depression-free days during a 12-month period (95% CI, -1.5 to 29.3). Incremental costs of the intervention were $273 (95% CI, $102 to $418) for depression treatment costs only and $160 (95% CI, -$173 to $512) for total outpatient costs. Incremental cost-effectiveness ratio was $24 per depression-free day (95% CI, -$59 to $496) for depression treatment costs only and $14 per depression-free day (95% CI, -$35 to $248) for total outpatient costs. CONCLUSIONS: A program to prevent depression relapse in primary care yields modest increases in days free of depression and modest increases in treatment costs. These modest differences reflect high rates of treatment in usual care. Along with other recent studies, these findings suggest that improved care of depression in primary care is a prudent investment of health care resources.

Overview

Integrity signals

Registry

Crossref · 10.1097/00005650-200210000-00011

Cites

31 of 31 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 31 references

Research works printed but not linked: 2

  1. Sherbourne, 2002, Med Care, 40, 00
  2. Pyne, 1997, Psychopharmacol Bull, 33, 23

Cited by

See all 119

Metadata

Authors
Simon, G. E., Von Korff, M., Ludman, E. J., Katon, W. J., Rutter, C., Unützer, J., Lin, E. H. B., Bush, T., & Walker, E.
Affiliations
  • Group Health Cooperative (US)
  • University of Washington (US)
  • University of California, Los Angeles (US)
Corresponding author
  • Simon, Gregory E.
  • Ludman, Evette J.
  • Lin, Elizabeth H.B.
  • Bush, Terry
Venue
Medical Care
Published
2002-10
Volume
40
Issue
10
Pages
941-950
ISSN
0025-7079 (ISSN-L)
OpenAlex
W2085349108
Cited by
115
References
31
Citations by year
2026: 1 · 2025: 1 · 2021: 2 · 2020: 3 · 2019: 4 · 2018: 3 · 2017: 1 · 2015: 5 · 2014: 3 · 2013: 4 · 2012: 7
FWCI
23.43
Type
journal article
Language
en
Open access
closed
Locations
  • Medical Care (publishedVersion)
  • PubMed (publishedVersion)
Funders
National Institute of Mental Health (R01MH041739, MH4-1739)
Topics
  • Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Health Systems, Economic Evaluations, Quality of Life
  • Health Sciences › Medicine › Psychiatry and Mental health › Mental Health Treatment and Access
  • Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
Keywords
depression relapse prevention, primary care, cost-effectiveness, recurrent depression, dysthymia, antidepressant maintenance, shared decision-making, psychoeducation, medication adherence monitoring, health care costs
MeSH terms
Antidepressive Agents, Cost-Benefit Analysis, Depressive Disorder, Humans, Interviews as Topic, Preventive Health Services, Primary Health Care, Recurrence, Washington, Program Evaluation, Confidence Intervals, Chi-Square Distribution, Treatment Outcome, Episode of Care

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Cost-Effectiveness of a Program to Prevent Depression Relapse in Primary Care. https://app.cochat.ai/papers/10.1097/00005650-200210000-00011
The paper
Simon, G. E., Von Korff, M., Ludman, E. J., Katon, W. J., Rutter, C., Unützer, J., Lin, E. H. B., Bush, T., & Walker, E. (2002). Cost-Effectiveness of a Program to Prevent Depression Relapse in Primary Care. Medical Care. https://doi.org/10.1097/00005650-200210000-00011

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.